Kobe University-Ushio Inc. Joint Study Shows Irradiation of Filtered 222nm UV-C Light on Human Skin Reduces Bacterial Counts While Causing No Skin Damage
Ushio Inc. (Head Office: Tokyo, President and CEO: Koji Naito) and a research group led by Dr. Ryosuke Kuroda, Chairman and Professor of the Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, have completed a research study that shows that irradiation of filtered 222nm UV-C light on human skin reduces bacterial counts while causing no injury to the skin. This is the first study on the safety of 222nm UV-C light conducted on humans. The research paper regarding this study is published on PLOS ONE and can be accessed here.
For more information, please see below. (You will jump to Ushio America's website.)
For more information, please see below. (You will jump to Ushio America's website.)